Cargando…
Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study
BACKGROUND: Chronic migraine (CM) is a type of chronic daily headache. CM presents a challenge to primary care physicians and neurologists. Any new treatment showing efficiency would therefore be of great importance. Atenolol together with other beta-blockers is a first-line choice in episodic migra...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786076/ https://www.ncbi.nlm.nih.gov/pubmed/24083117 http://dx.doi.org/10.1186/2193-1801-2-479 |